» Articles » PMID: 37341888

Decoding the 'Fifth' Nucleotide: Impact of RNA Pseudouridylation on Gene Expression and Human Disease

Overview
Journal Mol Biotechnol
Publisher Springer
Date 2023 Jun 21
PMID 37341888
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular RNAs, both coding and noncoding are adorned by > 100 chemical modifications, which impact various facets of RNA metabolism and gene expression. Very often derailments in these modifications are associated with a plethora of human diseases. One of the most oldest of such modification is pseudouridylation of RNA, wherein uridine is converted to a pseudouridine (Ψ) via an isomerization reaction. When discovered, Ψ was referred to as the 'fifth nucleotide' and is chemically distinct from uridine and any other known nucleotides. Experimental evidence accumulated over the past six decades, coupled together with the recent technological advances in pseudouridine detection, suggest the presence of pseudouridine on messenger RNA, as well as on diverse classes of non-coding RNA in human cells. RNA pseudouridylation has widespread effects on cellular RNA metabolism and gene expression, primarily via stabilizing RNA conformations and destabilizing interactions with RNA-binding proteins. However, much remains to be understood about the RNA targets and their recognition by the pseudouridylation machinery, the regulation of RNA pseudouridylation, and its crosstalk with other RNA modifications and gene regulatory processes. In this review, we summarize the mechanism and molecular machinery involved in depositing pseudouridine on target RNAs, molecular functions of RNA pseudouridylation, tools to detect pseudouridines, the role of RNA pseudouridylation in human diseases like cancer, and finally, the potential of pseudouridine to serve as a biomarker and as an attractive therapeutic target.

Citing Articles

Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives.

Jia S, Yu X, Deng N, Zheng C, Ju M, Wang F Clin Transl Med. 2025; 15(1):e70190.

PMID: 39834094 PMC: 11746961. DOI: 10.1002/ctm2.70190.


RNA Stability: A Review of the Role of Structural Features and Environmental Conditions.

Kornienko I, Aramova O, Tishchenko A, Rudoy D, Chikindas M Molecules. 2025; 29(24.

PMID: 39770066 PMC: 11676819. DOI: 10.3390/molecules29245978.


N6-methyladenosine RNA modification in head and neck squamous cell carcinoma (HNSCC): current status and future insights.

Janakiraman P, Jayaprakash J, Muralidharan S, Narayan K, Khandelia P Med Oncol. 2024; 42(1):12.

PMID: 39580759 DOI: 10.1007/s12032-024-02566-4.


Role of RNA modifications in blood development and regeneration.

Gunage R, Zon L Exp Hematol. 2024; 138:104279.

PMID: 39009277 PMC: 11415282. DOI: 10.1016/j.exphem.2024.104279.


Epitranscriptomic Regulations in the Heart.

Benak D, Kolar F, Hlavackova M Physiol Res. 2024; 73(Suppl 1):S185-S198.

PMID: 38634649 PMC: 11412340. DOI: 10.33549/physiolres.935265.


References
1.
Karthiya R, Khandelia P . m6A RNA Methylation: Ramifications for Gene Expression and Human Health. Mol Biotechnol. 2020; 62(10):467-484. DOI: 10.1007/s12033-020-00269-5. View

2.
Machnicka M, Milanowska K, Oglou O, Purta E, Kurkowska M, Olchowik A . MODOMICS: a database of RNA modification pathways--2013 update. Nucleic Acids Res. 2012; 41(Database issue):D262-7. PMC: 3531130. DOI: 10.1093/nar/gks1007. View

3.
Karthiya R, Wasil S, Khandelia P . Emerging role of N4-acetylcytidine modification of RNA in gene regulation and cellular functions. Mol Biol Rep. 2020; 47(11):9189-9199. DOI: 10.1007/s11033-020-05963-w. View

4.
Zhao B, Roundtree I, He C . Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2016; 18(1):31-42. PMC: 5167638. DOI: 10.1038/nrm.2016.132. View

5.
Nachtergaele S, He C . Chemical Modifications in the Life of an mRNA Transcript. Annu Rev Genet. 2018; 52:349-372. PMC: 6436393. DOI: 10.1146/annurev-genet-120417-031522. View